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To determine parental awareness of influenza vaccination recommendations for children




South Australian parents with a telephone listing in the Electronic White Pages were ran-
domly selected.
Methods
Participants were interviewed using Computer Assisted Telephone Interviewing (CATI) dur-
ing May–July 2016. Univariable and multivariable analyses explored characteristics associ-
ated with awareness; with the survey data weighted to reflect the population of SA and the
probability of selection within a household.
Results
Of 539 parents, 33% were aware of the recommendation that all children (<5 years) should
receive the influenza vaccine annually with 51.9% aware that children with special risk medi-
cal conditions (SRMC) should also receive the vaccine annually. Characteristics strongly
associated with parental awareness of the recommendation for children aged < 5 years
were knowledge of recommendation for children with a SRMC (adjusted Odds Ratio [aOR]
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10.46, CI 4.44–24.63) or living in a metropolitan area (aOR 2.91, CI 1.19–7.09). There was
lack of awareness in those not working (aOR 0.13, CI 0.04–0.47), with trade level education
(compared with high school) (aOR 0.25 CI, 0.09–0.71) and in those born in the UK or Ireland
(aOR 0.19, CI 0.04–0.85). Awareness of the recommendation for children with SRMC to
receive the vaccine was strongly associated with knowledge of the influenza recommenda-
tion for children <5 years (aOR 10.22, CI 4.39–23.77) or not being born in Australia [UK/ Ire-
land (aOR 7.63, CI 1.86–31.31); other (aOR 3.93, CI 0.94–16.42)]. The most influential
cues to future receipt were a general practitioner (GP) recommendation (63.8%) and provid-
ing influenza vaccine free for all children (37.6%). More parents who delayed or excluded
vaccines believed that their children’s vaccinations (in general) were unnecessary, as other
children were vaccinated (42.8%) compared to those with no or minor concerns (11.1%)
(p<0.0001).
Conclusions
Parental awareness of children’s influenza vaccine recommendations is low. Targeted com-
munication strategies and resources are required to establish broader community aware-
ness of recommendations. Healthcare provider endorsement of the vaccine remains key
and health care professionals, particularly GPs and paediatric specialists should be encour-
aged to discuss influenza vaccine with parents at every opportunity. Many parents have vac-
cine concerns and addressing concerns across the spectrum of hesitancy is crucial.
Introduction
Influenza is the leading cause of vaccine preventable hospitalisations for Australian children
aged under 5 years. [1, 2] Children experience considerable disease burden with a higher
annual incidence than adults. Ten to forty percent of children are infected each year, which
increases considerably in children attending day-care. [3–5] Children also shed higher levels of
the virus for a longer period, contributing to the virus’ circulation within the community.[6–8]
Attributable healthcare costs of influenza in children are substantial, as are indirect economic
losses including lost productivity through parents needing time off work to care for infected
children and subsequent secondary transmission in households. [9–11]
In recent times, changes to recommendations, funding, the 2009/2010 pandemic and a clus-
ter of serious adverse events with use of the BioCSL Fluvax vaccine have contributed to the
changing landscape of children’s influenza vaccination in Australia (Fig 1). Influenza vaccine
coverage in Australian children has been poor, with previous uptake reported between 14–
23% in children aged<18 years [12–15]. More recent 2018 data reports coverage for children
aged<5 years ranges between 19–43.4% across jurisdictions (25.6% overall). [16] Estimated
coverage is 30–44% for children with special risk medical conditions (SRMC)[12, 17, 18].
SRMC: Special Risk Medical Condition; mo: months; yrs: years. ACT: Australian Capital
Territory; NSW: New South Wales; QLD: Queensland; SA: South Australia; TAS: Tasmania;
VIC: Victoria; NT: Northern Territory; WA: Western Australia. Reference: National Centre
for Immunisation Research and Surveillance (NCIRS). Significant events in influenza vaccina-
tion in Australia: NCIRS Fact sheet. Significant events in influenza vaccination in Australia:
NCIRS Fact sheet April 2019. [19]
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Fig 1. Brief timeline of children’s seasonal influenza vaccination recommendations, funding and events in Australia.
https://doi.org/10.1371/journal.pone.0230425.g001
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The influenza vaccine is free to those eligible under Australia’s National Seasonal Influenza
Vaccination and at a cost to non-eligible people, with the vaccine accessible through medical
practices, community immunisation clinics, hospitals, community children’s health clinics
and Aboriginal Health Centres. Community pharmacies may also administer the vaccine at a
cost, dependent on the jurisdiction and a person’s age.
While a doctor’s recommendation is considered central to influenza vaccine uptake in chil-
dren [12, 17, 20–24], much of the previous research examining factors related to vaccine
uptake in children in both Australia and elsewhere [12, 17, 20–23, 25–28] was undertaken in
children hospitalised or with SRMC. However, it is likely that general parental awareness of
children’s influenza recommendations also contributes to uptake and there is limited research
on parental awareness from a community perspective.
Only 50% of parents in a recent Australian study knew the vaccine was recommended for
children < 5 years, while another found higher uptake if parents believed the vaccine was rec-
ommended for their child’s age group or with the same medical condition as their child. [12,
13] Lack of parental awareness of the recommendation is cited as a common reason for non-
vaccination in children with SRMC [29] and hospitalised children [20].
Understanding parental awareness towards recommendations is essential in planning and
developing strategies to increase uptake. The primary aim of this study was to examine paren-
tal awareness of influenza vaccine recommendations and explore associated characteristics.
The study also sought to describe influences towards future receipt of the influenza vaccine,
examine patterns of information provision and decision making towards vaccination in gen-
eral, from a random sample of parents residing in South Australia (SA).
Methods
Study design
This study used data collected as part of a cross-sectional telephone survey. Study findings are
reported with consideration of the STROBE statement.[30]
Study setting
The survey was performed as part of the ‘Health Monitor’ program administered by the Popu-
lation Research and Outcomes Studies Unit, University of Adelaide, with the study population
recruited from the approximate 765,786 households located in metropolitan and rural South
Australia during May–July 2016.
Study recruitment
For this study, South Australian adults aged>18 years who were the parent or caregiver, referred
to hereafter as parents, of a child aged<18 years were eligible to participate. Participants were
members of households randomly selected from the SA Electronic White Pages (EWP) telephone
listings in SA. For each household, the adult aged 18 years or older with the most recent birthday
was selected for an interview. Each individual parent interviewed represents a separate household.
Selected persons were non-replaceable, and interviews were not conducted with alternative house-
hold members if the selected person was not available. Up to 10 call-backs were made to each
household before the selected individual was classified as a non-contact.
Ethical approval was granted from The University of Adelaide, and the SA Health HREC.
Potential participants were informed of the purpose of the survey and timeframe, its voluntary
nature and that they could decline or refuse questions at any stage of the survey or withdraw
completely at any time. Consent was implied by participation.
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Parental survey questionnaire
An independent external research company conducted Computer Assisted Telephone Inter-
views (CATI) whereby the interviewer followed a script provided by a computer and entered
participant responses directly into a database. At the beginning of the dialogue, interviewers
stated that they were calling on behalf of The University of Adelaide to conduct a survey on a
range of health issues. There was an introductory sentence for each health topic covered in the
survey and specific questions could be directed towards subgroups, such as parents. All data
collected were non-identifiable. A pilot study of 50 randomly selected households tested ques-
tion format and sequence. The questionnaire was designed so that each interview took on aver-
age 15 minutes or less to be completed.
Respondents who identified as a parent (of a child aged<18 years) were asked their aware-
ness of children’s influenza vaccination recommendations and influencing factors towards
future vaccine receipt for their child. Possible responses to future intentions towards influenza
immunisation and immunisation service use were read to participants with the option for mul-
tiple response. Respondents could also specify another response, that was later recoded. To
examine parental attitudes towards vaccines in general, parents were asked to state their beliefs
towards vaccine necessity, side effects, access to services, behaviour towards their child receiv-
ing vaccines and their level of concern according to the Vaccine Communication Framework
(VCF). [31] To examine immunisation service use, parents were asked their immunisation
provider type, decision-making surrounding their choice as well as any difficulties with access.
Parents were also asked their views on information surrounding where to obtain vaccinations
and to rate their child’s most recent vaccination service. Parents were instructed to answer all
immunisation specific questions in relation to their youngest child.
Statistical analysis
The survey data were weighted by the inverse of the individual’s probability of selection and
the number of times their telephone number(s) is(are) listed in the EWP, then re-weighted to
age group by sex by section of state (metropolitan/country) benchmarks derived from the June
2014 ABS Estimated Resident Population. Weighting corrected the distributions in the sample
data to approximate those of the SA population. The weights generated for the wider study
population were then maintained for the parental subset. Both as an expansion of the data and
as a matter of adjustment for non-response and non-coverage, resulting in data that is repre-
sentative of the population rather than limited to the households that responded.
Additional response questions were coded using content analysis and grouped into catego-
ries. Characteristics associated with awareness of the current influenza recommendations for
children were explored in successive multivariable logistic regression models. All the variables
were included and grouped together in blocks, facilitating an understanding of each group of
variables role in explaining awareness.
These variable blocks representing different constructs, may be important in understanding
vaccination awareness. The explanatory variable blocks were demographic variables, parental
beliefs/attitudes and health service use/awareness of other influenza recommendations. Unad-
justed odds ratios (OR) and adjusted OR (aOR) were presented with their 95% confidence inter-
vals (CI). In this paper, the crude versus final model is presented, with S1 and S2 Tables showing
full models. We examined level of parental concern according to the VCF. To further explore this,
we summed the total number of questions each participant had responded to, in a negative or
opposing way to 4 other questions related to vaccination beliefs and safety. Those who responded
in the neutral category were not included (neither agree/disagree) as an expression of hesitancy.
We used Stata (Version 14.1) for all statistical analyses (StataCorp, Texas, USA).
PLOS ONE Children’s seasonal influenza vaccination recommendations
PLOS ONE | https://doi.org/10.1371/journal.pone.0230425 April 9, 2020 5 / 20
Results
Study population
From 5,200 households randomly selected to participate, 2,118 households could not be con-
tacted or were non-residential telephone numbers. From the remaining 3,082 telephone num-
bers, 2,006 interviews were conducted, a participation rate of 64.8%. After the raw data were
weighted, 547 (27.3%) participants were parents, with 539 providing complete data.
Description of study sample
In the weighted sample, the mean age of parents was 41.5 years (95% CI 40.0–42.9) (Table 1).
There were slightly more female parents (53.3%), with the majority Australian born (n = 436;
80.9%) and speaking English as the predominant household language (91.9%, n = 496). Most
households were situated in metropolitan Adelaide (77.5%, n = 418) while 22.5% (n = 121)
were rural/regional residences, closely reflecting the proportion of households in metropolitan
versus rural South Australia.
Table 1. Household demographics of survey participants.
Participant characteristic Eligible parents# Parents# with complete data †
Raw N = 285 Raw N = 279 Weighted (N = 539)
Level n (%) n% n%
Age (years) 25–34 27 (9.5) 26 (9.3) 121 (22.5)
35–44 102 (35.8) 101 (36.2) 236 (43.8)
45–54 117 (41.1) 115 (41.2) 152 (28.2)
55 and over 39 (13.7) 37 (13.3) 30 (5.6)
Gender Male 105 (36.8) 105 (37.6) 252 (46.7)
Female 180 (63.2) 174 (62.4) 288 (53.3)
Residence Regional 94 (33.0) 93 (33.3) 121 (22.5)
Metropolitan 191 (67.0) 186 (66.7) 418 (77.5)
Country of Birth Australia 238 (83.5) 234 (83.9) 436 (80.9)
U.K. / Ireland 18 (6.3) 18 (6.5) 33 (6.1)
Other 29 (10.2) 27 (9.7) 70 (13.1)
Main language in household English 276 (96.8) 270 (96.8) 496 (91.9)
Non-English 9 (3.2) 9 (3.2) 44 (8.1)
Educational attainment High School or less 75 (26.3) 72 (25.8) 148 (27.4)
Trade Certificate 101 (35.4) 99 (35.5) 173 (32.0)
Bachelor or higher 109 (38.3) 108 (38.7) 219 (40.6)
Employment Full time 137 (48.1) 135 (48.4) 292 (54.2)
Part time/casual 99 (34.7) 99 (35.5) 166 (30.8)
Not working 49 (17.2) 45 (16.1) 82 (15.1)
Household income Up to $30,000 19 (6.7) 18 (6.5) 36 (6.7)
$30,001 - $50,000 36 (12.6) 34 (12.2) 48 (8.9)
$50,001 - $80,000 41 (14.4) 40 (14.3) 90 (16.6)
$80,001 - $100,000 44 (15.4) 44 (15.8) 75 (13.9)
More than $100,000 116 (40.7) 115 (41.2) 231 (42.8)
Don’t know/not stated 29 (10.2) 28 (10.0) 60 (11.1)
weighting can result in minor rounding variations.
#Participants who indicated they were the parent or caregiver of a child under the age of 18 years.
† We removed participants listwise with missing data for any of the variables included in the analysis (raw data n = 6).
https://doi.org/10.1371/journal.pone.0230425.t001
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Awareness of seasonal influenza vaccination recommendations for children
and characteristics associated with awareness
In total, 32.8% (n = 177) of parents were aware that all children aged>6months to 5 years are
recommended to receive the influenza vaccine whereas 51.4% of parents (n = 277) were aware
of the recommendation that children with SRMCs should receive the influenza vaccine. Only
26% (n = 141) of parents were aware of both recommendations. The proportion of parents
who were aware of the recommendation for children with a SRMC to receive the vaccine was
higher in parents who were aware of the recommendation towards all children < 5 years (140/
177, 79.1%) compared with parents who were not aware of the recommendation for
children < 5 years (136/362, 37.6%) (p<0.0001).
In the fully adjusted models (Table 2), awareness of the recommendation for children <5
years to receive the vaccine was strongly associated with knowledge of the influenza recom-
mendation for children with a SRMC (aOR 10.46, CI 4.44–24.63) or living in a metropolitan
area (aOR 2.91, CI 1.19–7.09) (Table 2). The model also indicated a lack of awareness in those
not working (aOR 0.13, CI 0.04–0.47), with trade level education (compared with high school)
(aOR 0.25 CI, 0.09–0.71) and in those born in the UK or Ireland (aOR 0.19, CI 0.04–0.85).
Whilst awareness of the recommendation for children with SRMC to receive the vaccine was
Table 2. Multivariable results for the effect of characteristics on awareness of the influenza vaccine recommendations for children aged< 5 years and children with
SRMC (N = 539).
Awareness of the influenza vaccine
recommendations for children aged < 5 years
Awareness of the influenza vaccine
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strongly associated with knowledge of the influenza recommendation for children <5 years
(aOR 10.22, CI 4.39–23.77) or not being born in Australia [UK/ Ireland (aOR 7.63, CI 1.86–
31.31); other (aOR 3.93, CI 0.94–16.42)]. The model also indicated awareness in female partici-
pants (aOR 2.47, CI 0.97–6.31).
Table 2. (Continued)
Awareness of the influenza vaccine
recommendations for children aged < 5 years
Awareness of the influenza vaccine




crude Adjusted Model all
covariates




p value OR 95%
CI
p value OR 95%
CI
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GP: general practitioner; SRMC: Special Risk Medical Conditions; Disagree
� included disagree/ strongly disagree; Agree
�� included agree/ strongly agree; No/ low importance
# included responses ‘Not at all/somewhat important’
## included Important/ Very important
† included a combination of providers (from MP or clinics)
††other were school (n = 9), hospital (n = 4), chemist (n = 4), Aboriginal Health Service (n = 4) and ’Could not recall’ (n = 2).
https://doi.org/10.1371/journal.pone.0230425.t002
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Future influenza vaccination cues to action
Parents indicated a GP recommendation as the most influential cue to future influenza vacci-
nation receipt (63.8%, n = 344) (Fig 2). This was followed by access to the vaccine at no cost
for all children (37.6%, n = 203), greater awareness through mass media (34.1%, n = 184) with
a third (32.4%, n = 175) citing the belief in the benefit of the vaccine as a key influence. Exclud-
ing parents who did not vaccinate altogether(n = 9), 41.6% (221/530) vaccinating parents were
in favour of their child receiving the influenza vaccine from a pharmacy in the future, 48.3%
were opposed and 10% undecided. Higher support for pharmacy provision came from parents
in regional areas (48.8% versus 39.7% metropolitan), those working full (45%) or part time
(45.7%) compared with those not working (21.7%) and in parents with lower educational
attainment (high school (47.7%), trade 42.2% or bachelor (37.2%)).
"What would be most influential for you in deciding to have your child receive a flu vac-
cine?" Multiple response—numbers will not total. GP: general practitioner.
Vaccination in general
Decision-making. Overall, 23.8% expressed either minor (19.8%) or high (4.0%) concern
towards vaccination in general yet still vaccinated; 1.9% delayed or excluded vaccines and
1.7% did not vaccinate at all. While 72.6% of parents reported having no concerns towards vac-
cination 15.2% (59/391) of this group’s responses to other vaccination belief questions indi-
cated views opposing vaccination (S1 Fig). Of those reporting no concerns, 3.6% believed that
vaccination is unnecessary to protect children, 10.2% thought vaccination was unnecessary as
others are vaccinated, while 4.5% of this group held safety concerns. There were significant
Fig 2. Potential influences towards future influenza vaccine receipt (N = 539).
https://doi.org/10.1371/journal.pone.0230425.g002
PLOS ONE Children’s seasonal influenza vaccination recommendations
PLOS ONE | https://doi.org/10.1371/journal.pone.0230425 April 9, 2020 9 / 20
differences for specific vaccination beliefs based on a parent’s level of concern and behaviour
towards vaccination (Fig 3). A higher proportion of parents who had no or minor concerns
towards vaccination agreed/ strongly agreed that vaccines were necessary to protect their chil-
dren (96.6%) compared to parents who reported a high level of concern (59.3%) or who
delayed or excluded vaccines (41.7%) (p<0.0001) (S3 Table). Of concern, a higher proportion
of parents who delayed or excluded vaccines reported agreeing /strongly agreeing that their
children’s vaccinations were unnecessary as other children were vaccinated (42.8%) compared
to those with no or minor concerns (10.9%) (p<0.0001). Over half of parents who delayed or
excluded vaccines agreed/ strongly agreed that serious side effects were too common to accept
(61.2%) compared to those with no or minor concerns (5.6%) (p<0.0001). A higher propor-
tion of parents who delayed or excluded vaccines agreed/ strongly agreed that vaccination ser-
vices were difficult to access (19.9%) compared to parents who reported a high level of concern
(2.8%) or who had no or minor concerns (2.5%) (p = 0.005).
Immunisation service use (n = 530). All parents except those (n = 9) who indicated that
their child did not receive any vaccinations provided information on their child’s most recent
immunisation service. Children’s immunisations were received from their general practitioner
(GP) (67%, n = 355.3), community immunisation clinic (8.4%, n = 44), child health clinic
(4.3%, n = 23) or combination of clinics (16.2%) (Fig 4). Choice of immunisation provider was
driven by proximity of the service to their home or easy access to (47.4%, n = 251) (S4 Table).
Additionally, parents cited the immunisation service having their medical records (30.3%),
being trustworthy (25.7%) or that a medical doctor provided the service (16.2%) as a reason
for their choice of provider.
Fig 3. Parental agreement towards vaccination beliefs by level of concern towards vaccination (N = 539). � parent has vaccination concerns, but
child receives all vaccines.
https://doi.org/10.1371/journal.pone.0230425.g003
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Cost and satisfaction with service. A small percentage of vaccinating parents (n = 72,
13.6%) recalled paying for the service to see their immunisation provider, such as medical
practice, to obtain their child’s most recent vaccination, with a further 8% (n = 42) unable to
recall. There was high satisfaction with the experience with 93.8% rating it as good or excellent
and less than two percent of vaccinating parents (1.6%, n = 8) rating their child’s most recent
vaccination service as fair or poor.
Sources of information on places to receive immunisations. A quarter (25.7%, n = 137)
of vaccinating parents thought there was insufficient information on where they could obtain
a vaccination for their child, with a further 6.9% undecided. Parents obtained information on
the location of immunisation services from a variety of sources (S2 Fig). The major sources
were medical practice (53.1%), news media (newspaper, radio or internet) (20%) and friends
or other parents (12%).
Discussion
For parents, vaccination decision making on behalf of their children can be a complex process.
Awareness of the schedule and current recommendations forms a considerable part of this
process and a cue to further action. Our study found only low to moderate awareness towards
influenza vaccine recommendations for children.
Our finding of modest parental awareness of the influenza vaccination recommendation
for children <5 years is lower than another Australian study [13] where 20% of parents incor-
rectly believed it is not recommended in this age group, with another 30% unsure. This Austra-
lian study reports the level of parent’s awareness towards the influenza vaccine
recommendations for children from a community sample. Although, a recent study also found
moderate awareness of the recommendation in parents of children with SRMCs [17], a much
Fig 4. Children’s immunisation providers (N = 530). These data exclude parents who did not vaccinate (n = 9; weighted data).
Parents could only nominate one place. #: other were vaccinations administered by Aboriginal Health Service home visit (n = 4)
and pharmacy (n = 4); † any combination of either family medical practitioner, community clinic or child health clinic.
https://doi.org/10.1371/journal.pone.0230425.g004
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higher proportion of those who were aware of the recommendation were likely to receive it,
even in the absence of a healthcare professional’s recommendation.
In our study, the strongest characteristic associated with awareness of the recommendation
for children <5 was awareness of the recommendation for children with SRMC. However,
given the change in effect size from the crude to final model, it is likely that some of the effect
of ‘awareness of the SRMC recommendation’ was influenced by other variables. Being born in
the UK/Ireland was also associated with lack of awareness with the difference in effect size
between the crude and final adjusted model indicating little influence from other variables in
the model. We also found a positive effect for residing in a metropolitan area that remained
consistent, with little fluctuation in OR from the crude analysis to the final adjusted model
indicating little influence from other variables in the model. The reason why residing in a met-
ropolitan area showed such a strong effect is unclear. Research has previously identified
regional GPs (non-metro) to be less likely to discuss non-funded immunisations. [32] While it
is possible that this may indicate variability in access to GPs and medical care or an inadequate
approach to influenza campaign messaging in general for regional areas, it may also be reflec-
tive of the health promotion messages and health education in regional areas more generally.
The negative effect of not being employed also remained constant as did having trade level
qualifications. It is possible that the type and amount of workforce participation mediate expo-
sure to vaccination messages in general.
Our model exploring awareness of the recommendation for children with SRMC revealed
the strongest characteristics associated with awareness was awareness of the recommendation
for children <5 and being born outside Australia. Being a female participant was also associ-
ated with awareness of this recommendation and could reflect the fact that mothers are more
likely to the primary carer of children with SRMC. The contrasting awareness towards the rec-
ommendations based on country of birth is interesting and possibly reflects policies towards
recommendations in other countries. To further examine this and to test for the effect between
‘Aware of influenza recommendation. . .’ and other model variables, we included the related
awareness variable last in each of the models and found it had only slight effect on other vari-
ables. For awareness of the recommendation (children < 5 years) the significance of immuni-
sation provider diminished. It is possible that this had more to do with smaller numbers
receiving vaccines at a community clinic (compared to GP) whilst influence of country of
birth increased, with reduction in the boundaries and point estimate for those from UK/Ire-
land. Whilst for awareness of the recommendation for children with SRMC, the inverse is true
with parents from Australia less likely to be aware of this recommendation.
Immunisation service use
Our study showed a similar pattern of immunisation service use to that reported previously
[33] with 66.7–82.9% of our sample receiving children’s vaccinations from their family GP.
Our finding that the most influential factor for a child’s future influenza vaccination, nomi-
nated by parents, was a GP recommendation, is consistent with previous research that found a
key facilitator for hospitalised children or children with SRMC was healthcare provider (HCP)
recommendation. [12, 17, 20–24, 34] However, little has focused specifically on the cues to
action towards influenza vaccination for children in general.
Influenza vaccine access
Our study identified that access to vaccines may be problematic for particular groups of
parents. More specifically, we found that parents who delayed or excluded vaccines reported
finding vaccination services difficult to access. Additionally, that two in five parents would be
PLOS ONE Children’s seasonal influenza vaccination recommendations
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willing for their child to receive the influenza vaccine from a pharmacy is also worth highlight-
ing. Although Australian pharmacists began administering the influenza vaccine from 2014
(with variation across jurisdictions), only some states have recently endorsed delivery to chil-
dren as young as 10 years of age. [35, 36] In contrast, pharmacists in several countries includ-
ing Argentina, the United Kingdom (UK), Canada, Portugal, New Zealand and the USA
(United States of America) have been administering the influenza vaccine for almost a decade.
[37–39] With Canada, Argentina, the UK and several states in the USA also endorsing phar-
macist administration to young children, with deviation in the minimum age requirement
across countries. [37–39] In order to improve access, alternative delivery sites should be given
consideration. Although generally Australian children do not start schooling until 5 years of
age, one delivery option could be school-based influenza vaccination programs, such as those
implemented in the UK and the USA [40, 41], delivery in childcare or pre-school programs or
broader access through community clinics at extended times which would improve access
overall, particularly during the peak influenza vaccination season.
Community awareness of influenza vaccine
It is important to place community awareness within the context of recent Australian influenza
vaccination events (Fig 1). In South Australia, at the time of this study the influenza vaccine
was recommended but not funded for all children aged>6 months to< 5 years, although will
be funded from 2020 as part of the NIP. [19] Our finding that a key motivator for 38.1% of
parents was access to the vaccine at no cost is lower than other Australian studies reporting
48–55% of parents would be motivated by a free annual vaccine [13, 42] and this variance may
be attributable to between study differences in the way data were obtained. These same studies
also report stronger parental support towards a free influenza vaccine, than the actual cost
being a financial barrier. [13, 42] The implications of a recommended but non-funded vaccine
are well documented, with increased parental support for vaccines included on the NIP. [42,
43] This is also true of providers, with enhanced support for government funded vaccines and
lower perceptions of disease severity towards non-funded vaccines previously noted.[32] Gov-
ernment funding implies to parents and providers alike that the vaccine is a priority, thereby
influencing the decision-making process. Consideration of the implications of vaccine funding
is therefore essential in the context of planning vaccination programs.
Parental vaccine concerns
A third of parents (32.8%) reported belief in the vaccine’s safety and being beneficial to the
child as a motivator to future vaccine receipt. Concerns about vaccine safety has remained a
barrier to influenza vaccination in children complicated by the serious adverse events in 2010.
[43, 44] Yet even prior to this, parental belief in the vaccine’s safety was shown to be associated
with support for vaccination. [42] More recent studies have also found belief in the vaccine’s
safety to be positively associated with vaccine uptake [12] but also suggest that negative public-
ity has lingered, complicated by parental knowledge towards the vaccine itself with a percep-
tion that the vaccine has not been around long enough, qualified by ensuring the safety of the
vaccine. [45] Current data is encouraging however, as despite a 2017 poll indicating just 12%
of parents believed the vaccine was safe this increased to 61% when the same poll was under-
taken in 2018.[13, 46] This may have been influenced by 2017 being a high burden influenza
season, with a number of deaths reported throughout Australia. [47]
Despite high recognition as to the importance of vaccines among parents in our study, a
considerable number had vaccine concerns according to the Vaccine Communication Frame-
work.[31] Parents who delayed or excluded vaccines placed lower importance on
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immunisation and doubted the necessity of vaccination to protect children. Worryingly, com-
parable proportions of parents who were highly concerned towards vaccinations also held
these beliefs. Also consistent with recent literature were vaccine safety concerns [48–51] how-
ever, the high number of parents citing ‘free-riding’ logic as a reason not to vaccinate is also of
concern and is higher than other recent Australian studies [15, 48, 49] and may indicate a
need to address both the importance and benefits of vaccinations for these parents. The fact
that parents who reportedly had no hesitations to vaccinate answered one or more questions
about vaccination beliefs in an opposing way suggests that decision-making is complex and
integrates many external factors. Understanding all the barriers to vaccination is important
and while scales to determine the extent of parental hesitancy exist [52] establishing a tool on
which to measure and categorise the broader spectrum of hesitancy is needed. Addressing
parent’s vaccination concerns especially among those who are more hesitant is critical and
requires an understanding of individual concerns, and provider communication, as
highlighted previously [53], remains a key determinant of vaccine hesitancy. Moreover, GPs as
primary health care providers play a key role in the immunisation landscape and have a pivotal
role in providing recommendations for key targeted groups and new vaccines. [54–56] Given
the high engagement of GPs in vaccination delivery, they remain in a key position of influence
to support vaccine decision making, and communication resources such as SKAI—Sharing
Knowledge About Immunisation [57] have been developed to assist in this process.
Previously much attention has focused on influenza recommendations for the elderly and
the adult SRMC population with little attention paid to the awareness of influenza vaccination
for children with SRMCs and children in general. The success of public health interventions
rests of the swell of community attitudes towards such interventions and policies, the balance
of perceived threat and risk of the intervention. Prior to this stage, however the community
needs to be aware that a potential problem exists and be supplied with cues to action. A lack of
awareness on the part of parents or HCPs may translate to missed opportunities for influenza
decision making. Social norms may also influence community awareness, which has previ-
ously been highlighted in relation to children’s’ influenza vaccination [25, 42] and may warrant
further examination.
The strength of this study is the unique perspective on awareness of influenza vaccine rec-
ommendations, with participants randomly sampled with weighting applied to improve the
generalisability of the data. As a cross-sectional study however, it has some limitations.
Although the study was conducted prior to implementation of state funded vaccine programs
in Australia, our findings are still relevant to improving uptake of funded programs and have
relevance to countries that recommend but do not fund influenza vaccine. Our sample was
limited to those who spoke English and therefore the sample of non-English speaking parents
was small. This is relevant considering that ethnicity has been identified as a significant factor
in vaccination status [58, 59], with not speaking a country’s dominant language previously
highlighted as a barrier for influenza vaccination. [60, 61] Accordingly, eliciting the views of
non-English-speaking households is important to improving uptake in these groups. As the
Health Monitor used the EWP, people without a number listed would have been omitted from
the sampling frame. This is relevant considering that mobile-only households have increased
in South Australia from 5.2% in 2006 to 27.6% in 2013; while national estimates suggest that in
2016, 31% of Australian adults were mobile-only.[62, 63] The use of EWP increases the risk of
non-coverage bias and may limit generalisation of findings to the wider South Australian pop-
ulation, with mobile-only households reported to be more likely to contain younger people,
unemployed people, renters, and be of lower socio-economic status. [64] However, there is
also evidence that when taking into account living arrangements ‘parents and children’ and
‘single parent’ households comprise lower proportions of mobile only households, 22% and
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33% respectively, compared to people living in shared households (54%), boarders (41%) and
living alone (37%), suggesting parents may be less likely to be omitted compared to other pop-
ulations. [65] Possible confounders such as a child or parent history of a SRMC and vaccina-
tion status, ages and number of children in the household were also not collected. While this is
a limitation, the purpose of this study was not to determine associations for specific groups but
overall awareness within the ‘parent’ community. This is important given parents are influ-
enced by social interactions, values, beliefs and comparison to others when considering child-
hood vaccinations. [66] Thus, although healthcare provider messages are key, vaccine decision
making happens in conjunction with the indirect messaging from those around you, thereby
adding another layer of vaccine messaging within the community.
The study also did not identify Aboriginal and Torres Strait Islander People which is impor-
tant given Aboriginal and Torres Strait Islander children are recommended to receive the vac-
cine from 6-months of age and Aboriginal and Torres Strait Islander people of all ages are
currently funded on the NIP. This area requires further study, although high coverage (60%)
has been identified in the Northern Territory. [14] Even though parents were only from South
Australia, limited information exists in Australia on parental awareness of influenza vaccina-
tion recommendations for children in the community and patterns of immunisation service
use. Lessons learnt from this study could be applied to other jurisdictions around Australia,
given the current models for influenza vaccine delivery are similar.
Conclusions
Parents display low awareness of influenza vaccination recommendations for children, with
lower awareness based on place of residence, country of birth, workforce engagement and edu-
cation level. Developing targeted communication strategies and resources and comprehensive
media advertising could help to establish broader community awareness of recommendations
for children aged < 5 years and children of all ages with SRMCs. Improving HCP knowledge
of recommendations in rural communities as well as equitable assess to vaccines could
improve influenza vaccine uptake in these regions. Health care professionals, particularly GPs
and paediatric specialists should be encouraged to discuss influenza vaccine with parents at
every opportunity.
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